share_log

6-K: Transaction Notification

6-K: Transaction Notification

6-K：交易通知
美股SEC公告 ·  2024/10/11 09:58

Moomoo AI 已提取核心信息

On October 10, 2024, multiple GSK executives and Persons Closely Associated (PCAs) acquired ordinary shares through dividend reinvestment under the Company's Share Reward Plan. The transactions were executed on the London Stock Exchange at £15.2563 and £15.3577 per share.Key participants included CEO Emma Walmsley (26 shares), President Corporate Development David Redfern (71 shares), CEO of ViiV Healthcare Deborah Waterhouse (58 shares), and Company Secretary Victoria Whyte (71 shares in total). Other executives including the Chief People Officer, Chief Commercial Officer, and various SVPs also participated in smaller volumes.Notable PCA transactions included Iain Whyte, PCA of Company Secretary Victoria Whyte, who acquired 1,105 shares at £15.3577, representing the largest single transaction in this dividend reinvestment event.
On October 10, 2024, multiple GSK executives and Persons Closely Associated (PCAs) acquired ordinary shares through dividend reinvestment under the Company's Share Reward Plan. The transactions were executed on the London Stock Exchange at £15.2563 and £15.3577 per share.Key participants included CEO Emma Walmsley (26 shares), President Corporate Development David Redfern (71 shares), CEO of ViiV Healthcare Deborah Waterhouse (58 shares), and Company Secretary Victoria Whyte (71 shares in total). Other executives including the Chief People Officer, Chief Commercial Officer, and various SVPs also participated in smaller volumes.Notable PCA transactions included Iain Whyte, PCA of Company Secretary Victoria Whyte, who acquired 1,105 shares at £15.3577, representing the largest single transaction in this dividend reinvestment event.
在2024年10月10日，多位GSk高管及密切相关人士（PCA）通过公司的股份奖励计划进行股息再投资，购买了普通股。这些交易在伦敦证券交易所以每股15.2563英镑和15.3577英镑的价格执行。主要参与者包括首席执行官Emma Walmsley（26股），企业发展总裁David Redfern（71股），ViiV Healthcare首席执行官Deborah Waterhouse（58股）和公司秘书Victoria Whyte（共71股）。其他高管，包括首席人事官、首席商业官及其他各个高级副总裁也以较小的数量参与了此次交易。值得注意的PCA交易包括公司秘书Victoria Whyte的PCA Iain Whyte，他以15.3577英镑的价格购买了1,105股，这代表了此次股息再投资事件中最大的单笔交易。
在2024年10月10日，多位GSk高管及密切相关人士（PCA）通过公司的股份奖励计划进行股息再投资，购买了普通股。这些交易在伦敦证券交易所以每股15.2563英镑和15.3577英镑的价格执行。主要参与者包括首席执行官Emma Walmsley（26股），企业发展总裁David Redfern（71股），ViiV Healthcare首席执行官Deborah Waterhouse（58股）和公司秘书Victoria Whyte（共71股）。其他高管，包括首席人事官、首席商业官及其他各个高级副总裁也以较小的数量参与了此次交易。值得注意的PCA交易包括公司秘书Victoria Whyte的PCA Iain Whyte，他以15.3577英镑的价格购买了1,105股，这代表了此次股息再投资事件中最大的单笔交易。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Medicus Pharma
    MDCX
    -- 3.680
    Scilex Holding
    SCLX
    -- 0.354
    阿玛琳
    AMRN
    -- 0.612
    赛诺菲安万特
    SNY
    -- 54.500
    艾伯维公司
    ABBV
    -- 192.870
    解锁完整榜单
    热门讨论
    特朗普2.0时代开启，全球市场会如何演变？
    🎙️讨论： 1. 关税政策将如何影响美股、黄金、比特币等核心资产的走势？ 2. 在此背景下，有哪些投资机会值得关注？你会如何布局？ 展开
    MicroStrategy 2024年第四季度业绩电话会
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。